NASDAQ:MDGL - Madrigal Pharmaceuticals Price Target & Analyst Ratings

-2.56 (-2.81 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
Now: $88.54
50-Day Range
MA: $92.27
52-Week Range
Now: $88.54
Volume159,113 shs
Average Volume179,452 shs
Market Capitalization$1.37 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Madrigal Pharmaceuticals in the last 12 months. Their average twelve-month price target is $178.6250, suggesting that the stock has a possible upside of 101.74%. The high price target for MDGL is $250.00 and the low price target for MDGL is $126.00. There are currently 1 sell rating, 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.692.712.64
Ratings Breakdown: 1 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $178.6250$193.00$231.00$238.50
Price Target Upside: 101.74% upside87.07% upside123.43% upside91.20% upside

Madrigal Pharmaceuticals (NASDAQ:MDGL) Consensus Price Target History

Madrigal Pharmaceuticals (NASDAQ:MDGL) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2019B. RileySet Price TargetBuy$134.00HighView Rating Details
8/8/2019CowenReiterated RatingBuyLowView Rating Details
8/7/2019Stifel NicolausSet Price TargetHold$126.00LowView Rating Details
7/3/2019HC WainwrightReiterated RatingBuy$225.00LowView Rating Details
5/15/2019CitigroupLower Price TargetBuy$200.00 ➝ $186.00MediumView Rating Details
3/28/2019UBS GroupBoost Price TargetNeutral ➝ Positive$143.00MediumView Rating Details
2/22/2019Leerink SwannInitiated CoverageOutperformLowView Rating Details
2/22/2019Svb LeerinkInitiated CoverageOutperform$165.00MediumView Rating Details
12/14/2018Wolfe ResearchInitiated CoverageOutperform ➝ OutperformMediumView Rating Details
12/4/2018OppenheimerSet Price TargetBuy$200.00HighView Rating Details
11/19/2018Raymond JamesDowngradeMarket Perform ➝ UnderperformHighView Rating Details
11/16/2018Evercore ISIUpgradeIn-Line ➝ Outperform$222.00 ➝ $250.00HighView Rating Details
8/6/2018Goldman Sachs GroupDowngradeBuy ➝ Neutral$314.00MediumView Rating Details
6/1/2018Roth CapitalBoost Price TargetBuy$210.00 ➝ $400.00MediumView Rating Details
5/31/2018JMP SecuritiesReiterated RatingOutperform$150.00 ➝ $300.00HighView Rating Details
(Data available from 8/24/2017 forward)
This page was last updated on 8/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel